Is WeLeader Biomedical Co stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, WeLeader Biomedical Co pays dividends. Last time was Wednesday 10th of July 2024 where the investors holding the stock on Thursday 13th of June 2024 were paid TWD2.3 per share. Over the last 1 times between 2024 and 2024, WeLeader Biomedical Co has paid TWD2.3 with an average of TWD2.3 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for WeLeader Biomedical Co 10 years ago, but if you had invested on Tuesday 2nd of January 2024 when the price was TWD82.50, you would have made a loss of TWD-12.50 per share or -15.15%
No, the average daily trading liquidity for WeLeader Biomedical Co is TWD3 534 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
WeLeader Biomedical Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.46, the company's ability to pay off the debt is normal. WeLeader Biomedical Co has a good net profit margin of 16.52% and should have high tolerances against inflation.
We have calculated the inflation risk for WeLeader Biomedical Co to be low [0.4 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.